Affinite Instruments

Montreal, Canada Founded: 2015 • Age: 11 yrs
A portable SPR platform for molecular analysis is developed.

About Affinite Instruments

Affinite Instruments was founded in 2015 in Montreal, Canada, focusing on biotechnology instrumentation. A miniature, portable platform based on surface plasmon resonance is developed for applications in environmental monitoring, molecular diagnostics, drug screening, and materials characterization. The platform incorporates the P4SPR instrument, Afficoat peptide coating for immunoassay enhancement, and Microhole Array Technology for Vis-NIR SPR. Partnerships with established companies are being sought to expand applications.

People of Affinite Instruments

5 people are tracked at Affinite Instruments (3 in leadership, 2 in board & advisors).

NameRoleGroup
Jean Francois Masson
CEOLeadership
Ludovic Live
Co-Founder & CEOLeadership
Jean-François Masson
Co-Founder & CTOLeadership
Michael Atkin
Business Advisor & Board MemberBoard & advisors
Philippe Masson
Business Advisor & Board MemberBoard & advisors
Premium access

Complete people profiles for Affinite Instruments

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of Affinite Instruments

The website of Affinite Instruments (affiniteinstruments.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 25% vs previous month

Similar companies to Affinite Instruments

10 companies that operate in the same segment as Affinite Instruments (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Affinite Instruments

Affinite Instruments was founded in 2015.

Affinite Instruments is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

Jean Francois Masson is the current CEO of Affinite Instruments.

Affinite Instruments was founded in 2015 in Montreal, Canada, focusing on biotechnology instrumentation. A miniature, portable platform based on surface plasmon resonance is developed for applications in environmental monitoring, molecular diagnostics, drug screening, and materials characterization. The platform incorporates the P4SPR instrument, Afficoat peptide coating for immunoassay enhancement, and Microhole Array Technology for Vis-NIR SPR. Partnerships with established companies are being sought to expand applications.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available